Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review
Open Access
- 22 October 2014
- journal article
- review article
- Published by Elsevier BV in Saudi Pharmaceutical Journal
- Vol. 24 (4), 458-472
- https://doi.org/10.1016/j.jsps.2014.10.001
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Chronic ulcerative colitis and colorectal cancerCancer Letters, 2013
- Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: Formulation, optimization and in vitro evaluation / Alginatne mikrosfere naproksen natrija obložene Eudragitom S-100: Priprava, optimizacija i in vitro vrednovanjeActa Pharmaceutica, 2012
- Enhanced Transferrin Receptor Expression by Proinflammatory Cytokines in Enterocytes as a Means for Local Delivery of Drugs to Inflamed Gut MucosaPLOS ONE, 2011
- Colon-Specific Drug Delivery Behavior of pH-Responsive PMAA/Perlite CompositeInternational Journal of Molecular Sciences, 2010
- Colon Targeted Drug Delivery Systems: A Review on Primary and Novel ApproachesOman Medical Journal, 2010
- The fundamental basis of inflammatory bowel diseaseJCI Insight, 2007
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Development of Enteric-coated Timed-release Matrix Tablets for Colon TargetingJournal of Drug Targeting, 2004
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987